ow dose estrogen has no significant effect on bone fracture healing measured by pQCT in postmenopausal wome
Not Applicable
- Conditions
- S52.10M81.0Postmenopausal osteoporosis
- Registration Number
- DRKS00019858
- Lead Sponsor
- MGAbteilung: CUOP
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 94
Inclusion Criteria
postmenopausal female patients suffering from distal radius fractures
Exclusion Criteria
younger patients who are not in postmenopausal or male patients
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference of fracture healing process after 6 weeks of surgical intervention with k-wireing and estrogen treatment or no treatment (placebo Group) was measured with pQCT.
- Secondary Outcome Measures
Name Time Method Controlling of blood samples and measurement of estrogen blood levels after four and six weeks of surgical intervention.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Estrogen receptor signaling pathways bone fracture healing osteoblast osteoclast activity pQCT
Low-dose estrogen versus bisphosphonates SERMs comparative effectiveness postmenopausal fracture healing
Bone turnover markers CTX P1NP predict pQCT outcomes estrogen therapy fracture healing
Adverse events low-dose estrogen therapy postmenopausal women VTE breast cancer risk
RANKL inhibitors PTH analogues effects bone microarchitecture fracture healing postmenopausal osteoporosis